Date updated:05-10-2008
Stocks of companies involved in gene therapy, including stem cell companies and cord blood companies. By Stockerblog.com

-
ALNY
Alnylam Pharmaceu - $16.84
- -0.12%
- $16.98
develops therapeutic products based on RNA interference

-
CEGE
- $0.00
- 0.00%
- $N/A
a biotechnology company that develops cell-based cancer immunotherapies and oncolytic virus therapies

-
ENZ
Enzo Biochem Inc - $5.90
- +0.51%
- $5.83
biomedical research products and tools used in the fields of gene expression

-
GENZ
Genzyme Corporati - $50.05
- +0.85%
- $49.33
products and therapies relating to renal, therapeutics, transplants, biosurgery, and genetics

-
ISIS
Isis Pharmaceutic - $11.23
- +1.81%
- $10.92
RNA-based drugs

-
ONXX
Onyx Pharmaceutic - $27.99
- +0.36%
- $27.83
oral anticancer therapies used to prevent cancer cell proliferation and angiogenesis

-
ONXX
Onyx Pharmaceutic - $27.99
- +0.36%
- $27.83
oral anticancer therapies used to prevent cancer cell proliferation and angiogenesis
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. a sector pair but not an industry pair
AAPL/AMT
A. The only one I own : SLX,
too hard pick a winner out all of them
These are the stocks from Jim Cramer's Nov. 1 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more
Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more
Here are some of the largest % gainers from Nov. 20, 2009. more











Comments not available